Trials / Active Not Recruiting
Active Not RecruitingNCT05872763
A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery
An Observational Cohort Study of Patients With Newly Diagnosed Unresectable Stage IIIB, IIIC, or IV Non-Small-Cell Lung Cancer (NSCLC) in China
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (estimated)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, observational cohort study in China with both primary prospective data collection and retrospective collection of prior treatment information from medical records, which enrolls and follows patients who are newly diagnosed with unresectable stage IIIB/IIIC/IV Non-Small-Cell Lung Cancer (NSCLC) in the selected sites. This study aims to describe the clinical practice and long-term survival benefits of patients newly diagnosed with unresectable stage IIIB/IIIC/IV NSCLC. The study also seeks to explore the condition of biomarker tests utilization, and to assess potential economic impact on patients in the real world. The safety related events will also be summarized in this study.
Conditions
Timeline
- Start date
- 2023-08-11
- Primary completion
- 2026-11-06
- Completion
- 2026-11-06
- First posted
- 2023-05-24
- Last updated
- 2026-04-13
Locations
12 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05872763. Inclusion in this directory is not an endorsement.